Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer Book Section
| Author: | Robson, M. |
| Editors: | Hudis, C. A.; Traina, T. A. |
| Article/Chapter Title: | Poly(ADP-ribose) polymerase inhibitors in triple-negative breast cancer |
| Abstract: | Single-agent PARP inhibitors have produced responses in BRCA mutation-associated breast cancer. There are limited data regarding the effects of single-agent PARP inhibitors in sporadic TNBC. Combinations of PARP inhibitors with conventional cytotoxic agents are being studied in both hereditary and sporadic breast cancer. The results of the iniparib Phase III study may not generalize to other PARP inhibitor studies, given differences in patient populations and the activities of the compounds. © 2011 Future Medicine Ltd. All rights reserved. |
| Book Title: | Advances in the Management of Triple-Negative Breast Cancer |
| ISBN: | 9781780841069 |
| Publisher: | Future Medicine |
| Publication Place: | London, UK |
| Date Published: | 2011-10-01 |
| Start Page: | 61 |
| End Page: | 69 |
| Language: | English |
| DOI: | 10.2217/ebo.11.100 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Book Chapter: 6 -- Export Date: 3 March 2016 -- Source: Scopus |
